Amphastar P (AMPH)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.25B
Last updated: Nov 17, 2026 at 11:05 AM ET
Amphastar P (AMPH) P/E Ratio & Valuation History
Amphastar P (AMPH) trades at 10.3x trailing earnings and 1.7x sales. Its P/E of 10.3x is below its 5-year median of 12.4x. The median P/E across 11 similar companies is 12.7x.
Current Multiples
Its enterprise value is 7.6x its EBITDA. Its free cash flow yield is 11.2%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 10.3x |
| Forward P/E | N/A |
| Price to sales | 1.7x |
| Price to book | 1.5x |
| EV/EBITDA | 7.6x |
| Price to FCF | 8.9x |
| EV/FCF | 11.9x |
| PEG | 2.8 |
| FCF yield | 11.2% |
Historical Medians
Against its 10-year medians, its P/E is 56.5% below 23.7x, its P/S is 41.4% below 2.9x and its P/B is 40.0% below 2.5x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 10.3x | 12.4x | 23.7x |
| P/S | 1.7x | 3.0x | 2.9x |
| P/B | 1.5x | 2.9x | 2.5x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 8.8x in 2025 to 86.5x in 2018. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $26.78 | 8.8x | 1.7x | 1.6x |
| 2024 | $37.13 | 9.6x | 2.5x | 2.6x |
| 2023 | $61.85 | 18.7x | 4.8x | 5.1x |
| 2022 | $28.02 | 14.2x | 2.8x | 2.7x |
| 2021 | $23.29 | 17.1x | 2.6x | 2.6x |
| 2020 | $20.11 | 31.4x | 2.7x | 2.4x |
| 2019 | $19.29 | 55.1x | 2.8x | 2.4x |
| 2018 | $19.90 | 86.5x | 3.2x | 2.9x |
| 2017 | $19.24 | 52.0x | 3.8x | 2.8x |
| 2016 | $18.42 | 36.8x | 3.3x | 2.6x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About AMPH
Is AMPH stock overvalued?
GNG's valuation label for AMPH is Undervalued. Its P/E of 10.3x compares with a median of 12.7x across 11 similar companies.
What is AMPH's price to sales ratio?
Amphastar P has a price to sales ratio of 1.7x.
What is Amphastar P's average P/E ratio over 5 years?
Amphastar P's median P/E over the last 5 years is 12.4x, from 60 month-end values through Oct 2026.
What is AMPH's PEG ratio?
Amphastar P has a PEG ratio of 2.8.
AMPH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors